|
WO2021006850A2
|
|
Curcuminoid oral compositions comprising silica
|
|
WO2020091712A2
|
|
Pharmaceutical combinations for the treatment of pain
|
|
WO2020091711A1
|
|
Pharmaceutical combinations for the treatment of pain
|
|
WO2020018048A2
|
|
An immediate release pharmaceutical composition of anti-inflammatory drugs, famotidine and a carbonate
|
|
WO2020032883A2
|
|
Synergistic effects of a novel ketoprofen formulation including a gastro protective agent
|
|
WO2020013781A2
|
|
Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation
|
|
WO2020013776A2
|
|
Synergistic effect of naproxen and a gastro protective agent for the treatment of pain and inflammation
|
|
WO2020167262A1
|
|
Immediate release formulations of gel forming polymers
|
|
US2020022936A1
|
|
Combinations of diclofenac, h2 receptor antagonists and alkali metal bicarbonates for the treatment of pain and inflammation
|
|
WO2019135725A1
|
|
Combinations of selective cox-2 inhibitor nsaids and h2 receptor antagonists for fast treatment of pain and inflammation
|
|
US2019307713A1
|
|
Combinations of diclofenac and h2 receptor antagonists for the treatment of pain and inflammation
|
|
WO2018231176A2
|
|
Combinations of diclofenac and h2 receptor antagonists for the treatment of pain and inflammation
|
|
EP3474838A1
|
|
Surfactants for treatment of skin infections caused by double stranded dna viruses of the herpesviridae or papillomaviridae families
|
|
US2015125534A1
|
|
Imatinib solid dosage forms reconstituted just before use
|
